CFDB - Cystic Fibrosis DataBase

  1. Home
  2. Database
Search (?)
at least one term
all terms
Advanced search
ongoing trials trial from www.clinicaltrials.gov

Inhaled dry powder alginate oligosaccharide (OligoG) in cystic fibrosis: sub-group analyses of a double-blind, randomized, placebo-controlled, efficacy and safety trial

  • Year: 2019
  • Date:
  • Author: Rye P
Source

Respirology (Carlton, Vic.), 2019, 24, 141‐

Study design (if review, criteria of inclusion for studies)

Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT

Participants

ADULT, OLDER_ADULT

Interventions

DIAGNOSTIC_TEST: :PULMONARY FUNCTION TEST|DIAGNOSTIC_TEST: NASAL ENDOSCOPY| LEUKOSORB FILTER PAPER APPLICATION TO NASAL CAVITY|BEHAVIORAL: SINONASAL OUTCOME TEST 22 QUESTIONNAIRE|CYSTIC FIBROSIS QUESTIONNAIRE-REVISED|BEHAVIORAL: PATIENT HEALTH QUESTIONNAIRE-9|DRUG: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID

Outcome measures

SINONASAL OUTCOME TEST 22 QUESTIONNAIRE|PULMONARY FUNCTION TESTING WILL BE PERFORMED WITH THE FEV1/FVC . 12 weeks|Health Care Utilization, Need for additional doctor visits, antibiotics, oral steroids, 12 weeks|Nasal endoscopy, 12 weeks

Keywords: non pharmacological intervention - diagn; hydration; Hypertonic Solutions; Inhalation OR nebulised; pharmacological_intervention; Airway clearance drugs -expectorants- mucolytic- mucociliary-; Respiratory System Agents; Bacterial Infections; Isotonic Solutions; Respiratory Tract Infections; Sinusitis; Respiratory Tract Diseases;